TYPE 3 RESISTANT STARCH FROM CANNA EDULIS REDUCE LIPID LEVELS IN PATIENTS WITH MILD HYPERLIPIDEMIA THROUGH ALTERING GUT MICROBIOME: A DOUBLE- BLIND RANDOMIZED CONTROLLED TRIAL

Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial

Type 3 resistant starch from Canna edulis (Ce-RS3) is an insoluble dietary fiber which could improve blood lipids in animals, but clinically robust evidence is still lacking.We performed a double-blind randomized controlled trial to assess the effects of Ce-RS3 on lipids in mild hyperlipidemia.One hundred and fifteen patients were included followed

read more

Barriers and enablers to source plasma donation by gay, bisexual and other men who have sex with men under revised eligibility criteria: protocol for a multiple stakeholder feasibility study

Abstract Background Blood donation policy in Canada for gay, bisexual and other men who have had sex with men (gbMSM) has changed progressively in the last decade from indefinite deferral to 3-month deferral from last male-to-male sex.Driven by safety data and overseen by the national regulator, more inclusive policies continue to redress the dispa

read more